BioEngage

The latest in biosimilars

Get to know biosimilars
Get to know biosimilars: a primer
Learn More
Developing the totality of evidence for biosimilars: regulatory considerations for the healthcare community
Read Study
pharmacovigilance considerations for biosimilars in the usa
Read Study
biosimilars: clinical and scientific considerations
Read Report
manufacturing biosimilars: process And quality standards
manufacturing biosimilars: process And
quality standards
Learn More
ensuring a robust
raw-materials
supply chain
Read Article
Preventing shortages
of biologic medicines
Read Article
pharmacists discuss drug shortages
Watch Video
manufacturing biosimilars: process And quality standards
Managing unexpected events in the
manufacturing of biologic medicines
Learn More
substitution and interchangeability
DISTINCT THERAPEUTIC CHOICES
Learn More
Substitution and INTERCHANGEABILITY: Defining the Terms
Learn More
naming
Biologic medicines, including biosimilars, are unlike small-molecule traditional drugs made using chemical processes.
Learn More
the arrival of biosimvilars—what’s in a name
Watch Video
there is broad support
for distinguishable
names for biosimilars
Read Article
Formulary Selection Criteria for Biosimilars: Considerations for US Health-System Pharmacists
formulary selection criteria for biosimilars: considerations for us Health-system...
Read Article
substitution and interchangeability
interchangeability and substitution
worldwide
View Map
how the
fda defines
interchangeability
Learn More
take a closer look at
biosimilars: 2018 trends
in biosimilars report
Read Report
substitution and interchangeability
biologics & biosimilars: an overview
Learn More
substitution and interchangeability
The Future of Biosimilars in the USA: Mapping critical uncertainties and the impact of future events
Learn More